RecruitingNCT04664556
Invasive Pneumococcal Disease Study
Population-based Nationwide Study on Invasive Pneumococcal Infections Among Children (0-18 Years) in France
Sponsor
Association Clinique Thérapeutique Infantile du val de Marne
Enrollment
1,369 participants
Start Date
Dec 13, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
After 7 then 13 valent pneumococcal conjugate vaccine implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Eligibility
Min Age: 1 DayMax Age: 18 Years
Inclusion Criteria1
- Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood PCR.
Exclusion Criteria1
- Pneumococcal strain not transmetted to National Reference Center for Pneumococci or to Regional Pneumococci Observatory
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERobservational study
observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04664556
Related Trials
Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults
NCT0682290724 locations
Minocycline in Stroke Study at Maimonides
NCT072370481 location
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
NCT070177773 locations
A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma
NCT066214074 locations
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
NCT068939396 locations